  Recent studies have indicated that magnetic resonance imaging ( MRI) efficiently diagnoses lung cancer. However , the efficacy of MRI in diagnosing lung cancer requires improving for patients in the early stage of the disease. In the present study , a novel nano-sized contrast agent of chistosan/Fe